Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/47608
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
Metadatos
Mostrar el registro completo del ítem
EVALUATION OF URINE SARS-COV-2 RT-PCR AS A PREDICTOR OF ACUTE KIDNEY INJURY AND DISEASE SEVERITY IN PATIENTS WITH CRITICAL COVID-19
Síndrome Respiratória Aguda Grave
Reação em cadeia da polimerase
Lesão renal aguda
Coronavírus
Teste de vírus
Severe acute respiratory syndrome coronavirus 2
Polymerase chain reaction
Acute kidney injury
Coronavirus disease 2019
Virus testing
Autor
Afiliación
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil / Hospital Santo Antônio. Medicina Interna. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, BA, Brasil / Universidade Salvador. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Centro de Biotecnologia e Terapia Celular. Salvador, BA, Brasil / Instituto D'Or de Ensino e Pesquisa. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Centro de Biotecnologia e Terapia Celular. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Centro de Biotecnologia e Terapia Celular. Salvador, BA, Brasil / Instituto D'Or de Ensino e Pesquisa. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Centro de Biotecnologia e Terapia Celular. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Hospital São Rafael. Nefrologia. Salvador, BA, Brasil.
Resumen en ingles
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which began as an outbreak in Wuhan, China and has spread rapidly across the globe. Although most infections are mild, patients with severe and critical COVID-19 infections face deterioration of respiratory function and may also have extrapulmonary manifestations, mostly affecting the kidney, digestive tract, heart, and nervous system. Here, we prospectively evaluated the presence of SARS-CoV-2 genetic material using reverse-transcription polymerase chain reaction in urine samples obtained from patients with COVID-19 receiving critical care. Among 51 included patients, we found higher serum creatinine levels, a longer hospital stay, and more frequent need for dialysis in urine-positive patients. These findings could suggest that, in predisposed patients, a direct viral cytopathic effect may contribute to a more severe disease phenotype.
Palabras clave en portugues
UrinaSíndrome Respiratória Aguda Grave
Reação em cadeia da polimerase
Lesão renal aguda
Coronavírus
Teste de vírus
Palabras clave en ingles
UrineSevere acute respiratory syndrome coronavirus 2
Polymerase chain reaction
Acute kidney injury
Coronavirus disease 2019
Virus testing
Compartir